Original Research
Published on 01 May 2026
Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for Alzheimer’s disease therapy
in Drug Metabolism and Transport
- 281 views